全部

1·The diagnosis and treatment of breast carcinoma.

乳腺癌的诊断和治疗。

2·Pictured here is the flow cytometry pattern of a breast carcinoma.

图示：乳腺癌流式细胞仪模式图。

3·Breast carcinoma; Intercostobrachial nerve; Axillary lymph node dissection.

乳腺癌；肋间臂神经；腋窝淋巴结清扫。

4·Taoerqi; breast neoplasm; human breast carcinoma cell lines MCF7; apoptosis.

桃儿七；乳腺癌；人乳腺癌细胞系MCF7；雕亡。

5·Objective: To investigate the expression of decorin (DCN) in breast carcinoma.

目的：探讨核心蛋白聚糖(DCN)在乳腺癌中的表达。

6·Objective To investigate the risk factors of bone metastases in breast carcinoma.

目的研究乳腺癌骨转移的主要危险因素。

7·BRMS1 is a tumor metastasis suppressor gene discovered in breast carcinoma cells in 2000.

BRMS1是2000年在乳腺癌细胞中发现的癌转移抑制基因。

8·To study the expression of PLK1 and PCNA in breast carcinoma and its clinical significance.

目的探讨乳腺癌组织中PLK1、增殖细胞核抗原(pcna)的表达及其临床意义。

9·Methods The clinical data of 84 patients with breast carcinoma were analyzed retrospectively.

方法对我院84例乳腺癌病人进行回顾性分析。

10·In a female, unilateral axillary nodes raise the suspicion of an ipsilateral breast carcinoma.

在女性，单侧淋巴结肿大怀疑单侧乳腺癌。

乳腺癌

1·Conclusions: MMP-2 is an unfavorable prognostic factor in lymph node-negative breast carcinoma patients and it is an important prognostic factor.

结论：MMP - 2蛋白在淋巴结阴性乳腺癌转移复发中起着重要作用，是重要的预后因子。

2·BRMS1 is a tumor metastasis suppressor gene discovered in breast carcinoma cells in 2000.

BRMS1是2000年在乳腺癌细胞中发现的癌转移抑制基因。

3·In a female, unilateral axillary nodes raise the suspicion of an ipsilateral breast carcinoma.

在女性，单侧淋巴结肿大怀疑单侧乳腺癌。

4·Pictured here is the flow cytometry pattern of a breast carcinoma.

图示：乳腺癌流式细胞仪模式图。

5·OBJECTIVE: to observe the effect of dihydroartemisinin on the proliferation and apoptosis in human breast carcinoma cell line T47D in vitro and explore the mechanism.

目的：研究二氢青蒿素对乳腺癌细胞系t 47d的增殖、凋亡作用的影响，初步探讨其抗癌作用的分子机制。